Drug withdrawal syndrome in newborn
Drug Withdrawal Syndrome in Newborns
Drug withdrawal syndrome in newborns, also known as Neonatal Abstinence Syndrome (NAS), is a group of problems that occur in a newborn who was exposed to addictive opiate drugs while in the mother's womb.
Causes[edit | edit source]
Drug withdrawal syndrome in newborns is caused by the sudden discontinuation of fetal exposure to substances that were used or abused by the mother during pregnancy. These substances pass through the placenta and can lead to addiction and dependence in the fetus. The most common substances leading to NAS are opioids, but other substances can also cause the syndrome.
Symptoms[edit | edit source]
Symptoms of drug withdrawal syndrome in newborns can develop immediately or up to 14 days after birth and can vary in severity. Common symptoms include Blotchy skin coloring (mottling), Diarrhea, Excessive crying or high-pitched crying, Excessive sucking, Fever, Hyperactive reflexes, Increased muscle tone, Irritability, Poor feeding, Rapid breathing, Seizures, Sleep problems, Slow weight gain, Stuffy nose, sneezing, Sweating, Trembling (tremors), and Vomiting.
Diagnosis[edit | edit source]
Diagnosis of drug withdrawal syndrome in newborns is based on a physical examination of the baby and a history of the mother's drug use. The Finnegan scoring system is often used to quantify the severity of the withdrawal, monitoring for signs such as changes in eating, sleeping, and behavior.
Treatment[edit | edit source]
Treatment for drug withdrawal syndrome in newborns aims to relieve symptoms and may include medicines to treat or manage severe withdrawal symptoms, fluids given through a vein (IV) to prevent dehydration, and a higher-calorie formula to provide extra nutrition.
Prevention[edit | edit source]
Prevention of drug withdrawal syndrome in newborns involves addressing substance use in pregnant women. This can include Substance abuse counseling and treatment programs, as well as prenatal care to monitor the health of both the mother and the baby.
See also[edit | edit source]
Drug withdrawal syndrome in newborn Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD